Stock market week-in-review for 5 large GI companies — Aug. 14-18

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 14 to Aug. 18, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $232.28 on Aug. 14
Peaked: $235.83 on Aug. 14
Closed: $223.92 on Aug. 18
Percent change between Aug 14 to Aug. 18: -3.59 percent

2. Exact Sciences Corp.

Opened: $38.35 on Aug. 14
Peaked: $39.75 on Aug. 15
Closed: $37.87 on Aug. 18
Percent change between Aug 14 to Aug. 18: -1.25 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 14
Peaked: $134.72 on Aug. 16
Closed: $132.63 on Aug. 18
Percent change between Aug 14 to Aug. 18: -0.36 percent

4. Synergy Pharmaceuticals

Opened: $3.01 on Aug. 14
Peaked: $4.04 on Aug. 16
Closed: $2.92 on Aug. 18
Percent change between Aug 14 to Aug. 18: -2.99 percent

5. Valeant Pharmaceuticals

Opened: $14.12 on Aug. 14
Peaked: $14.81 on Aug. 17
Closed: $14.39 on Aug. 18
Percent change between Aug 14 to Aug. 18: 1.91 percent

More articles on gastroenterology:
Majority of ulcerative colitis patients not achieving clinical, endoscopic remission — 5 key notes
GI leader to know: Dr. Sarah Brendler of the Cascade Endoscopy Center
GI center to know: Cascade Endoscopy Center

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.